GUNA-FLU

Manufacturer: Guna spa
Effective date: 2022-11-14
Label type: HUMAN OTC DRUG LABEL
Version: 7
Source: full-release
Hydrated at: 2026-06-01 02:18:31

Label at a glance#

ProductGUNA-FLU

Active ingredientACONITUM NAPELLUS, CAIRINA MOSCHATA HEART/LIVER AUTOLYSATE, ASCLEPIAS CURASSAVICA, ATROPA BELLADONNA, COPPER, ECHINACEA ANGUSTIFOLIA, HAEMOPHILUS INFLUENZAE TYPE B

Label structure13 sections

Indications and uses

Uses : Temporary relief of cold and flu symptoms, such as: fever, headache, minor aches and pains.

Dosage and administration

Take on an empty stomach. Adults and children 12 years and older Take 1 tube contents to be dissolved in the mouth, every 6 hours, up to 3 times per day. Children between 12 years and 6 years of age. Take 1 tube contents to be dissolved into a little water, every 6 hours, up to 3 times per day. Children under 6 years Consult a physician.

Contacts and useful links#

PhoneLabel contact(484) 223-3500

Label contents#

Full prescribing information#

ACTIVE INGREDIENTS/PURPOSE

OTC - ACTIVE INGREDIENT SECTION

ACONITUM NAPELLUS 5C FEVER

ANAS BARBARIAE 200CK FLU-LIKE SYMPTOMS DUE TO BACTERIAL INFECTIONS

ASCLEPIAS VINCETOXICUM 5C FEVER DUE TO VIRAL INFECTIONS

BELLADONNA 5C FEVER

CUPRUM METALLICUM 3C HEADACHE, MUSCLE PAIN

ECHINACEA ANGUSTIFOLIA 3C IMMUNE SUPPORT

HAEMOPHILUS INFLUENZAE 9C FLU-LIKE SYMPTOMS DUE TO BACTERIAL INFECTIONS

USES

OTC - PURPOSE SECTION

Uses: Temporary relief of cold and flu symptoms, such as: fever, headache, minor aches and pains.

WARNINGS

OTC - STOP USE SECTION

Stop use and ask doctor if symptoms persist more than 5 days or worsen.

PREGNANCY

OTC - PREGNANCY OR BREAST FEEDING SECTION

If pregnant or breast-feeding ask a health professional before use.

WARNINGS

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Stop use and ask doctor if symptoms persist more than 5 days or worsen.
If pregnant or breast-feeding ask a health professional before use.
Keep out of reach of children.

DIRECTIONS

OTC - WHEN USING SECTION

Take on an empty stomach.
Adults and children 12 years and older   Take 1 tube contents to be dissolved in the mouth, every 6 hours, up to 3 times per day.
Children between 12 years and 6 years of age.   Take 1 tube contents to be dissolved into a little water, every 6 hours, up to 3 times per day.
Children under 6 years   Consult a physician.

QUESTIONS

OTC - QUESTIONS SECTION

Questions?: info@gunainc.com
tel. (484) 223-3500

DOSAGE & ADMINISTRATION SECTION

Adults and children 6 years and older: take 1 tube every 6 hours, up to 3 times per day.
Children under 6 years: Ask a doctor.

INDICATIONS & USAGE SECTION

Directions: pour the content of 1 tube directly into the mouth and allow to dissolve under the tongue. Take on an empty stomach.

INACTIVE INGREDIENT SECTION

Inactive Ingredient: Sucrose.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

keep out of reach of children.

WARNINGS SECTION

Stop use and ask doctor if symptoms persist more than 5 days or worsen.
If pregnant or breast-feeding ask a health professional before use.
Keep out of reach of children.

PRINCIPAL DISPLAY PANEL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

GUNA-FLU rev.8

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
c599c4a0-705d-4ebb-ab1f-977af038f96a	Product name	1	20251124

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
17089-025-17	GUNA-FLU	6 in 1 BOX	PELLET	6		7
17089-025-17	GUNA-FLU	1 g in 1 TUBE	PELLET	1		7

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
17089-025	GUNA-FLU (ACONITUM NAPELLUS - ASCLEPIAS CURASSAVICA - ATROPA BELLADONNA - CAIRINA MOSCHATA HEART/LIVER AUTOLYSATE - COPPER - ECHINACEA ANGUSTIFOLIA - HAEMOPHILUS INFLUENZAE TYPE B -) PELLET [GUNA SPA]	7	Current NDC, Legacy NDC, 2 package rows	20221115_84e8e18c-8a74-41d5-b285-1ecb788bba3d.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	SPL version
ACONITUM NAPELLUS	ACTIVE INGREDIENT	U0NQ8555JD	4
ASCLEPIAS CURASSAVICA	ACTIVE INGREDIENT	JSZ93E47EP	4
ATROPA BELLADONNA	ACTIVE INGREDIENT	WQZ3G9PF0H	4
CAIRINA MOSCHATA HEART/LIVER AUTOLYSATE	ACTIVE INGREDIENT	RN2HC612GY	4
COPPER	ACTIVE INGREDIENT	789U1901C5	4
ECHINACEA ANGUSTIFOLIA	ACTIVE INGREDIENT	VB06AV5US8	4
HAEMOPHILUS INFLUENZAE TYPE B	ACTIVE INGREDIENT	F2TW0N64FI	4
ACONITUM NAPELLUS	ACTIVE MOIETY	U0NQ8555JD	4
ASCLEPIAS CURASSAVICA	ACTIVE MOIETY	JSZ93E47EP	4
ATROPA BELLADONNA	ACTIVE MOIETY	WQZ3G9PF0H	4
CAIRINA MOSCHATA HEART/LIVER AUTOLYSATE	ACTIVE MOIETY	RN2HC612GY	4
COPPER	ACTIVE MOIETY	789U1901C5	4
ECHINACEA ANGUSTIFOLIA	ACTIVE MOIETY	VB06AV5US8	4
HAEMOPHILUS INFLUENZAE TYPE B	ACTIVE MOIETY	F2TW0N64FI	4
SUCROSE	INACTIVE INGREDIENT	C151H8M554	4

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 10 matching rows.

GUNA-FLU
ACONITUM NAPELLUS - ASCLEPIAS CURASSAVICA - ATROPA BELLADONNA - CAIRINA MOSCHATA HEART/LIVER AUTOLYSATE - COPPER - ECHINACEA ANGUSTIFOLIA - HAEMOPHILUS INFLUENZAE TYPE B -
SUCROSE
ACONITUM NAPELLUS
CAIRINA MOSCHATA HEART/LIVER AUTOLYSATE
ASCLEPIAS CURASSAVICA
ATROPA BELLADONNA
COPPER
ECHINACEA ANGUSTIFOLIA
HAEMOPHILUS INFLUENZAE TYPE B

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
17089-025	17089-025-17

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 8 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
SUCROSE	C151H8M554	IACT
ACONITUM NAPELLUS	U0NQ8555JD	ACTIB
CAIRINA MOSCHATA HEART/LIVER AUTOLYSATE	RN2HC612GY	ACTIB
ASCLEPIAS CURASSAVICA	JSZ93E47EP	ACTIB
ATROPA BELLADONNA	WQZ3G9PF0H	ACTIB
COPPER	789U1901C5	ACTIB
ECHINACEA ANGUSTIFOLIA	VB06AV5US8	ACTIB
HAEMOPHILUS INFLUENZAE TYPE B	F2TW0N64FI	ACTIB

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 2 · 62 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredient	IID ingredient	UNII	Dosage form / route	Potency	Maximum daily exposure	Match
SUCROSE	SUCROSE	C151H8M554	GRANULE, FOR SUSPENSION / ORAL		31885 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	CAPSULE, COATED, EXTENDED RELEASE / ORAL		86 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET, FILM COATED / ORAL		145 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET, DELAYED RELEASE / ORAL	295.33 mg		Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	PASTILLE / ORAL	426 mg		Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	SOLUTION / ORAL		70000 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	CAPSULE, DELAYED RELEASE / ORAL		955 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	CONCENTRATE / ORAL		4800 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET, COATED / ORAL	516.42 mg		Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	GRANULE / ORAL	NA		Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	GRANULE, FOR SOLUTION / ORAL		42596 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET, FILM COATED, EXTENDED RELEASE / ORAL	119.12 mg		Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET, FILM COATED / ORAL		145 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	SUSPENSION / ORAL		48209 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	CAPSULE, DELAYED RELEASE / ORAL		955 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	CAPSULE, EXTENDED RELEASE / ORAL		619 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	SUSPENSION/ DROPS / ORAL		3750 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TROCHE / ORAL	NA		Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	LIQUID / ORAL		37500 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	POWDER, FOR SUSPENSION / ORAL		40017 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET, CHEWABLE / ORAL		7258 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET, FILM COATED, EXTENDED RELEASE / ORAL	119.12 mg		Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	CAPSULE, COATED PELLETS / ORAL	59.8 mg		Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	SUSPENSION, EXTENDED RELEASE / ORAL		5400 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	POWDER, FOR SOLUTION / ORAL		38666 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET, EXTENDED RELEASE / ORAL	284.54 mg		Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	POWDER / ORAL		27768 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	CONCENTRATE / ORAL		4800 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	PASTILLE / ORAL	426 mg		Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	GRANULE, FOR SOLUTION / ORAL		42596 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET, CHEWABLE / ORAL		7258 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	POWDER, FOR SOLUTION / ORAL		38666 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	POWDER, FOR SUSPENSION / ORAL		40017 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET / ORAL		4249 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	ELIXIR / ORAL		18000 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	DROPS / ORAL	NA		Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	SUSPENSION, EXTENDED RELEASE / ORAL		5400 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	ELIXIR / ORAL		18000 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TROCHE / ORAL	NA		Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	CAPSULE, COATED, EXTENDED RELEASE / ORAL		86 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	LIQUID / ORAL		37500 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	GRANULE / ORAL	NA		Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	WAFER / ORAL	155.2 mg		Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	DROPS / ORAL	NA		Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	CAPSULE / ORAL		3568 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET / ORAL		4249 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	SYRUP / ORAL		46400 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	GRANULE, FOR SUSPENSION, EXTENDED RELEASE / ORAL		18790 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	SUSPENSION / ORAL		48209 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET, EXTENDED RELEASE / ORAL	284.54 mg		Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET, COATED / ORAL	516.42 mg		Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET, DELAYED RELEASE / ORAL	295.33 mg		Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	SYRUP / ORAL		46400 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	GRANULE, FOR SUSPENSION, EXTENDED RELEASE / ORAL		18790 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	CAPSULE, EXTENDED RELEASE / ORAL		619 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	GRANULE, FOR SUSPENSION / ORAL		31885 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	SUSPENSION/ DROPS / ORAL		3750 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	CAPSULE / ORAL		3568 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	SOLUTION / ORAL		70000 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	WAFER / ORAL	155.2 mg		Exact identifier — unii+route 62 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
GUNA-FLU	ACONITUM NAPELLUS - ASCLEPIAS CURASSAVICA - ATROPA BELLADONNA - CAIRINA MOSCHATA HEART/LIVER AUTOLYSATE - COPPER - ECHINACEA ANGUSTIFOLIA - HAEMOPHILUS INFLUENZAE TYPE B -	Guna spa	84e8e18c-8a74-41d5-b285-1ecb788bba3d	2022-11-14	Warnings	Exact identifier ndc (package): 17089-025-17 ndc (product): 17089-025 ndc11 (package): 17089002517 spl id: 92ac92a1-762e-5c83-e053-2995a90a3350 spl set id: 84e8e18c-8a74-41d5-b285-1ecb788bba3d

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.